Home/Filings/4/0000914190-13-000732
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-13-000732

CIK 0001180145operating

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 4:23 PM ET

Size

21.0 KB

Accession

0000914190-13-000732

Insider Transaction Report

Form 4
Period: 2013-10-22
Flaherty James E
Chief Administrative Officer
Transactions
  • Sale

    Common Stock

    2013-10-22$26.42/sh18,756$495,534149,992 total
  • Sale

    Common Stock

    2013-10-23$30.00/sh300$9,000132,366 total
  • Exercise/Conversion

    Common Stock

    2013-10-22$8.83/sh+8,624$76,150149,360 total
  • Sale

    Common Stock

    2013-10-22$27.25/sh17,626$480,309132,366 total
  • Exercise/Conversion

    Common Stock

    2013-10-22$7.90/sh+19,388$153,165168,748 total
  • Exercise/Conversion

    Common Stock

    2013-10-23$12.15/sh+300$3,645132,666 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-10-2219,3880 total
    Exercise: $7.90Exp: 2017-08-06Common Stock (19,388 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-10-228,6240 total
    Exercise: $8.83Exp: 2017-04-17Common Stock (8,624 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-10-2330023,820 total
    Exercise: $12.15Exp: 2017-12-11Common Stock (300 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-02Common Stock (10,999 underlying)
    10,999
Footnotes (4)
  • [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.97 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.56 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:23 PM ET
Size
21.0 KB